Synthesis of VIP-Lipopeptide Using a New Linker to Modify Liposomes: Towards the Development of a Drug Delivery System for Active Targeting

A new component for the solid phase peptide synthesis of lipopeptide, 2-[(4R,5R)-5-({[(9H-fluoren-9-yl)methoxy]carbonylaminomethyl}-2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]acetic acid (2), was designed and synthesized from (−)-2,3-O-isopropylidene- D -threitol (3) in 4 steps. The key step was the sel...

Full description

Saved in:
Bibliographic Details
Published inChemical & pharmaceutical bulletin Vol. 61; no. 11; pp. 1184 - 1187
Main Authors Masaka, Toru, Matsuda, Takuya, Li, Yingpeng, Koide, Yuki, Takami, Akira, Yano, Kenji, Imai, Ryosuke, Ichihara, Risa, Yagi, Nobuhiro, Suzuki, Hideharu, Hikawa, Hidemasa, Terada, Katsuhide, Yokoyama, Yuusaku
Format Journal Article
LanguageEnglish
Published TOKYO The Pharmaceutical Society of Japan 01.11.2013
Pharmaceutical Society of Japan
Pharmaceutical Soc Japan
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A new component for the solid phase peptide synthesis of lipopeptide, 2-[(4R,5R)-5-({[(9H-fluoren-9-yl)methoxy]carbonylaminomethyl}-2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]acetic acid (2), was designed and synthesized from (−)-2,3-O-isopropylidene- D -threitol (3) in 4 steps. The key step was the selective alkylation of 3 with benzyl bromoacetate in the presence of Cs2CO3. Vasoactive intestinal peptide (VIP)-lipopeptide (1) incorporating this linker was synthesized by solid phase peptide synthesis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0009-2363
1347-5223
DOI:10.1248/cpb.c13-00518